The most favorable strategies at this time, which are assessed against IgE-mediated allergic diseases, include the opportunity to use proteomics for the characterization of epitopes to develop new food allergy vaccines [36,37] and the use of immunomodulating peptides to stimulate oral tolerance toward food allergens or prevent allergic sensitization [38]. The gene discussed is IGHE; the disease is allergic disease.